Communicating emerging safety risks of marketed medicines
This course aims to provide you knowledge and understanding of the challenges met by regulatory agencies in risk communication.
At the end of the course, you will be able to:
Dr. Paul Benkimoun
Université de Bordeaux
Dr. Peter Mol
Principal Assessor of Pharmacotherapy Group II; cardiovascular, diabetes and female hormone products